Patents

US 12049467 B2: Substituted benzopyrazolo[1,5-a][1,4]diazepines as GABA positive allosteric modulators

Granted
2024-07-30
Filed
2022-02-01 application 17590404
Type
Utility · 25 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt thereof, or an N-oxide thereof) of formula (I), which are positive allosteric modulators of one or more GABA-A receptors, e.g., which are peripherally restricted, positive allosteric modulators of one or more GABA-A receptors; e.g., which are positive allosteric modulators of one or more GABA-A receptors and which selectively target the peripheral nervous system and organs of the body, and which do not substantially pass through the blood-brain barrier. Said compounds are useful e.g., for the treatment of systemic diseases of the body, e.g., diseases in which modulation of one or more peripherally restricted GABA-A receptors is beneficial (e.g., diseases or disorders which are mediated by GABA-A neuronal activity. This disclosure also features pharmaceutical compositions containing the chemical entities described herein as well as methods of using same for the treatment of systemic diseases of the body.

Source: PVGPATDIS, file of 2026-04-10 (ipg240730.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Johns Hopkins University 2,182 patentsUS company or organizationBaltimore, MDJohns Hopkins University College or university FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePVGPATDIS, file of 2026-04-10
Lieber Institute, Inc. 9 patentsUS company or organizationBaltimore, MDLIEBER INSTITUTE INC Nonprofit EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Yifang HuangLansdale, PA15PVGPATDIS, file of 2026-04-10
Pankaj J. PasrichaEllicott City, MD44PVGPATDIS, file of 2026-04-10
James C. BarrowArnold, MD29PVGPATDIS, file of 2026-04-10
Ingrid BuchlerBaltimore, MD4PVGPATDIS, file of 2026-04-10
Michael S. PoslusneyBaltimore, MD16PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D487/04PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/12PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2023-03-01Assignment
Assignment of assignor's interest
PASRICHA, PANKAJ JAY signed 2022-11-09THE JOHNS HOPKINS UNIVERSITY BALTIMORE, MD62840/109ECORSEXC, file of 2026-09-25
2022-08-11Assignment
Assignment of assignor's interest
BARROW, JAMES C. signed 2022-08-08
BUCHLER, INGRID signed 2022-08-08
HUANG, YIFANG signed 2022-08-08
POSLUSNEY, MICHAEL signed 2022-08-08
LIEBER INSTITUTE, INC., D/B/A THE LIEBER INSTITUTE FOR BRAIN DEVELOPMENT BALTIMORE, MD60785/566ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.